Prevalence of NAFLD in T1DM Patients

NARecruitingINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions

NAFLDType 1 DiabetesFatty Liver, Nonalcoholic

Interventions

DIAGNOSTIC_TEST

FibroScan

Performance of a FibroScan measurement to determine steatosis and fibrosis.

Trial Locations (1)

RECRUITING

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors

lead

Ziekenhuis Oost-Limburg

OTHER